Explore Clinical GI Science at ACG 2016 Annual Meeting

*EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 17, 2016 at 8:00 am EDT. Noteworthy Abstracts Highlight Cutting-Edge Clinical GI Science This page is a gateway to explore the ...

Poster 467 Significantly Improved Outcomes for U.S. Liver Transplant Candidates with HCV

*EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 17, 2016 at 8:00 am EDT. Ju Dong Yang, MD, MSc Poster 467 Significantly Improved Outcomes for U.S. Liver Transplant Candidates ...

Poster 111 Colorectal Cancer and Racial Disparity: Gut Microbiome as a Potential Regulator

*EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 17, 2016 at 8:00 am EDT. Adhip Majumdar, PhD, DSc Poster 111 Colorectal Cancer and Racial Disparity: Gut Microbiome as a Potential ...

Poster 13 Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials

*EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 17, 2016 at 8:00 am EDT. Poster 13 Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: ...

Oral 9 A Placebo-Controlled Trial of Pregabalin for Irritable Bowel Syndrome

*EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 17, 2016 at 8:00 am EDT. Yuri A. Saito, MD, MPH Oral 9 A Placebo-Controlled Trial of Pregabalin for Irritable Bowel Syndrome Author ...

Oral 19 A Randomized, Double-Blind, Placebo-Controlled Trial of a Novel Recombinant, Humanized, Anti-Interleukin-13 Monoclonal Antibody (RPC4046) in Patients with Active Eosinophilic Esophagitis: Results of the HEROES Study

*EMBARGOED All research presented at the ACG Annual Scientific Meeting is strictly embargoed until Monday, October 17, 2016 at 8:00 am EDT. Evan S. Dellon, MD, MPH Oral 19 A Randomized, Double-Blind, Placebo-Controlled Trial of a Novel Recombinant, ...